TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Emergency Nursing Knowledge Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Learning Engagement Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Course Satisfaction Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ischemia-reperfusion injury in liver grafts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fetal distress rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Visual analogue scale - pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Side bridge test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk flexion test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk extension test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: modified Harris Hip Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Patient Mobility Levels
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of subjects in remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lipid core burden index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of recovery-15 (QoR-15) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Minimal Residual Disease (MRD) detection using flow cytometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimal Residual Disease (MRD) detection using Next Generation Sequencing (NGS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean power output at different %1RM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak power output at different %1RM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of repetitions performed in 1 set at 65%1RM until task failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Histological diagnosis of AKD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of patients evaluable for assessments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of patients adherent to Fit4Surgery intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: P-selectin assessed as median fluorescence intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PAC-1 assessed as median fluorescence intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Platelet aggregation in response to physiologic agonist, assessed as percent of maximum aggregation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Binge Eating Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Patient Health Questionnaire-9 Item Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Area under the curve - AUC0-t
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed concentration - Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of the maximum observed concentration - Tmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee injury and Osteoarthritis Outcome score (KOOS PS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Range of Motion (Goniometer)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum level of procalcitonin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of Ureteroenteric Stricture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Growth hormone area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: AVF maturation status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Neovascular changes during nAMD relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: IgG seropositivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Weight Z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number, severity and duration of treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Tolerated Dose (MTD) and/or Biological effective dose (BED)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of serious treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: TEAEs leading to discontinuation of study treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Fatal TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: 30-Day Readmission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Abridged Bowel Disease Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Leuven Postprandial Distress Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Oxytocin concentration in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: New incidence or exacerbation of a pre-existing neurologic disorder or prior rheumatologic or other autoimmune disorder
Endpoint domain: Adverse events/effects
Primary endpoint: Exhaled VOC Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve from time zero to time infinity (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerance of levamisole
Endpoint domain: Adverse events/effects
Primary endpoint: Ratio of target microRNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dopamine response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Height Growth at Month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Study Drug-Related Grade 3 or Higher Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Observed Serum Concentration (Cmax) of ABBV-382
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Cmax (Tmax) of ABBV-382
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term safety of RGX-314
Endpoint domain: Adverse events/effects
Primary endpoint: Analog visual eyestrain test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot and Ankle Ability Measure (FAAM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Diary Defense and Veterans Pain Rating Scale (DVPRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ultrasound Measurement (Plantar fascial thickness)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: delayed onset of muscle soreness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diagnostic success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perspectives on cascade screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reach
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: need for invasive mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to definitive Health-Related Quality of life score Deterioration
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Hospitalization-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Subjective Visual Comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Visual Fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Successful glucocorticoid reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PET/CT scan images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Comparison of 89Zr-S095012 tumour uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful completion of telehealth
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Area under the curve (AUC) of the Lung ultrasound score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in patient reported outcomes as measured by PRO2 scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Inflammatory Markers as measured by blood C-reactive protein (CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in inflammatory markers as measured by fecal calprotectin lab results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of eligible women who receive breast cancer risk assessment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: General Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to First Reaching a Hughes Functional Grade (FG) Score <=1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calcon Calculator
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in BP during head up tilt test (HUTT) from baseline to after completion of 8 weeks of TCSCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in rectal pressure measured by anorectal manometry (ARM) from baseline to after completion of 8 weeks of TCSCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in intravesical pressure at first sensation measured by urodynamic investigation (UDI) from baseline to after completion of 8 weeks of TCSCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Accuracy of intra-abdominal pressure measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resin bonded bridge retention/survival
Endpoint domain: Mortality/survival
Primary endpoint: Change in smoking status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mass balance recovery of total radioactivity in all excreta: CumAe
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Determination of routes and rates of elimination of [14C]RIST4721 by Ae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Modified Yale Preoperative Anxiety Scale (mYPAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of participants with clinically meaningful change from baseline in laboratory Tests Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with clinically meaningful change from baseline in vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Daily Prosthesis Use Duration
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Urinary tract related questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: King's Health Quality of Life Questionnaire (KHQ)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Gray matter volume during MRI scan & stimulant use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: White matter integrity during MRI scan & stimulant use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relapse to/change in stimulant use post-release
Endpoint domain: Adverse events/effects
Primary endpoint: Risky driving events
Endpoint domain: Adverse events/effects
Primary endpoint: Unsafe driving behaviors
Endpoint domain: Adverse events/effects
Primary endpoint: Microcalcification activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in the Meaning in Life Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Post-traumatic Growth Inventory-X
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Demonstrated Skill score in communicating with their teens about sexual health
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cognitive function testing
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline HOMA-IR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Inhibition of pain-related spinal reflex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibition of pain-evoked cortical potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICDAS scores of initial caries or white spot lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of growth forming units of microbial strains
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Genetic expression of target genes of S. Mutans and L. Rhamnosus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: R0 resection rate
Endpoint domain: Mortality/survival
Primary endpoint: 1-year event-free survival (EFS) rate
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants who Experience Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Discontinuing Study Treatment due to AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Concentration (Cmax) of Nemtabrutinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of eligible patients willing to participate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients compliant with the study protocol
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients lost to follow up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adenomas per colonoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Concordance rate of duplicate prescriptions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of patients with glycaemia level within target
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: sensitivity of AutocathFFR measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: specificity of AutocathFFR measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: accuracy of AutocathFFR measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of mean monthly migraine days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Homeostasis Model Assessment (HOMA-IR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Four-Habits-Coding-Scheme scale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in microbial colonization of S. salivarius M18
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Locomotor Skills - Run
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Locomotor skills - Gallop
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Locomotor skills - Hop
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Adverse Event (AEs) and Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Quadriceps femoris strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biceps brachii strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper extremity flexibility-Back scratch test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative use of analgesic drugs (sufentanil) up to 48 hours postoperative
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Safety of in vivo measurement of lymph nodes
Endpoint domain: Adverse events/effects
Primary endpoint: Change in The Pulmonary Embolism Quality of Life (PEmb-QoL) questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in food security category
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in utility security category
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in financial well-being scale
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in perceived stress scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in state anxiety scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in mental bandwidth
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in health care expenditures on medications
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Attendance at a cardiovascular appointment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of ABBV-903
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Cmax (Tmax) of ABBV-903
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first occurrence of combined endpoint events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive predictive value (PPV) of EC/EG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants negative via EC/EG who are proven negative via EGD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of automatic evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of patients with lymphocyte repopulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Double lumen tube insertion times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotional appearance assessed by Emotional Appearance Scale for Children
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Radiation exposure levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systolic and diastolic blood pressure monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oxygen saturation monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical remission rate of diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum Preptin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of hairs in the target area of the scalp
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of proteins in blood (proteome)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cardiac function: concentrations (pg/ml) of NT-proBNP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximal strength of upper and lower extremity muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NRS scale
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Change in serum cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in Motor Development on the BSID-III
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in maturation of motor skills on the AIMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in infant motor behaviour on the IMP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Clinically Significant Changes in Laboratory Test Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Clinically Significant Changes in Vital Signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychosocial questionnaires
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient's experience of the disease
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ICU Survival
Endpoint domain: Mortality/survival